# Bolus vs IVP (Intravenous Push) Diltiazem for Atrial Fibrillation or Flutter

Study · id `cardio:ct-nct04141553` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04141553](<https://clinicaltrials.gov/study/NCT04141553>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04141553

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.

## Technical summary

Registry record NCT04141553. Randomized; single masking; primary purpose treatment. Start 2019-12-01 (anticipated); primary completion 2021-12-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 300 participants (planned count; ClinicalTrials.gov record NCT04141553, source copy `cardio:ctgov-nct04141553-2019-10-28`, retrieved 2026-10-26)
- Planned start: 2019-12-01 (anticipated) (ClinicalTrials.gov record NCT04141553, source copy `cardio:ctgov-nct04141553-2019-10-28`, retrieved 2026-10-26)
- Primary completion: 2021-12-01 (anticipated) (ClinicalTrials.gov record NCT04141553, source copy `cardio:ctgov-nct04141553-2019-10-28`, retrieved 2026-10-26)
- Completion: 2021-12-01 (anticipated) (ClinicalTrials.gov record NCT04141553, source copy `cardio:ctgov-nct04141553-2019-10-28`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04141553-2019-10-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Bolus vs IVP (Intravenous Push) Diltiazem for Atrial Fibrillation or Flutter
- Condition: Atrial Fibrillation
- Condition: Atrial Flutter
- Condition: Rapid Ventricular Response
- Intervention (Drug): Diltiazem Injection
- Lead sponsor: Mercy Health Muskegon
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Atrial flutter (`cardio:atrial-flutter`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Diltiazem (`cardio:diltiazem`)
- Registry intervention is a member of this class by a sourced record link: Calcium channel blockers (`cardio:calcium-channel-blockers`)

## Provenance

Content hash: 2aafac6fc05d1379324df2aa827ae11f40661e6fa7840ae6a03144fd8216e1b2
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
